Karyopharm Therapeutics Inc (KPTI)
1.08
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
1.08
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Gross Profit (Quarterly): 32.26M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 32.26M |
September 30, 2023 | 35.10M |
June 30, 2023 | 36.38M |
March 31, 2023 | 37.35M |
December 31, 2022 | 31.71M |
September 30, 2022 | 35.16M |
June 30, 2022 | 38.74M |
March 31, 2022 | 46.24M |
December 31, 2021 | 125.53M |
September 30, 2021 | 37.10M |
June 30, 2021 | 21.46M |
Date | Value |
---|---|
March 31, 2021 | 22.33M |
December 31, 2020 | 34.05M |
September 30, 2020 | 20.90M |
June 30, 2020 | 33.12M |
March 31, 2020 | 17.32M |
December 31, 2019 | 16.70M |
September 30, 2019 | 12.14M |
June 30, 2019 | 9.493M |
March 31, 2019 | 0.155M |
December 31, 2018 | 0.206M |
September 30, 2018 | 0.239M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
9.493M
Minimum
Jun 2019
125.53M
Maximum
Dec 2021
33.85M
Average
33.12M
Median
Jun 2020
Gross Profit (Quarterly) Benchmarks
Geron Corp | -- |
Arbutus Biopharma Corp | -- |
Verastem Inc | -- |
Actinium Pharmaceuticals Inc | -- |
Chimerix Inc | 0.004M |